Af. Weinmann et al., CLINICAL CORRELATES AMONG 49 FAMILIES WITH HEMOPHILIA-A AND FACTOR-VIII GENE INVERSIONS, American journal of hematology, 51(3), 1996, pp. 192-199
Inversions between a gene A copy within intron 22 of the factor VIII g
ene and additional copies outside the factor VIII gene were found in 4
9 families with hemophilia A. Inversion patterns were that of recombin
ation with a distal gene A copy in 34, a proximal copy in 14, and a th
ird (variant) copy in one, Baseline factor VIII clotting activity leve
ls were <1% of normal in 43 and 1% in 6. No inversion was detected in
61 other families whose affected members had less than or equal to 1%
activity levels nor in 42 families with moderately severe hemophilia A
and 2-5% baseline levels. Both high titer and low level alloantibody
inhibitors were found in patients with or without an inversion. Of 13
high titer inhibitors, 8 were persistent and 1 of these patients had a
n inversion. Of 5 that responded to daily factor VIII infusions, 4 wer
e in patients with gene inversions. Of the 49 families with an inversi
on, the occurrence of hemophilia was isolated in 30 and the mother was
a carrier in the 25 in which additional family members were informati
ve. In three of these families with isolated occurrence, the maternal
grandmother was a carrier whereas in three others a de novo mutation o
ccurred in the maternal grandfather's factor VIII gene. Screening for
gene inversions in patients with severe (or ''borderline'' severe) hem
ophilia A provides a direct marker of the mutation in 45% of families.
It is useful even if there is no living affected member and in predic
ting the likely severity of an infant in which there are no reliable b
aseline clotting activities, including 70% of families with isolated o
ccurrences of hemophilia A. (C) 1996 Wiley-Liss, Inc.